Question

Difficulty: MediumInfectious Diseases

An 8282-year-old male is admitted to the inpatient ward after developing a high fever, severe global headache, and worsening lethargy over the past 2424 hours. His medical history includes hypertension, type 2 diabetes mellitus, and benign prostatic hyperplasia. Upon arrival, his temperature is 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure is 112/68 mmHg112/68\text{ mmHg}, and pulse is 108/min108\text{/min}. Physical examination demonstrates marked nuchal rigidity and disorientation to time and place. A lumbar puncture is promptly performed, and cerebrospinal fluid (CSF) analysis reveals a leukocyte count of 1,200/μL1,200/\mu\text{L} with 85%85\% neutrophils, a glucose level of 35 mg/dL35\text{ mg/dL}, and a protein level of 140 mg/dL140\text{ mg/dL}. He is empirically started on intravenous ceftriaxone, vancomycin, ampicillin, and dexamethasone. Two days later, the CSF culture confirms the growth of *Listeria monocytogenes*. Which of the following is the most appropriate next step in the antimicrobial management of this patient?

  1. Discontinue ceftriaxone and vancomycin, and continue ampicillinAnswer
  2. B
    Discontinue ampicillin, and continue ceftriaxone and vancomycin
  3. C
    Continue the initial empirical antimicrobial regimen without modifications
  4. D
    Replace all current antibiotics with intravenous cefepime
  5. E
    Replace all current antibiotics with intravenous meropenem

Answer

Discontinue ceftriaxone and vancomycin, and continue ampicillin.
The correct action is to discontinue ceftriaxone and vancomycin, while continuing ampicillin. Ampicillin is the targeted drug of choice for Listeria monocytogenes meningitis. Cephalosporins, including ceftriaxone, lack activity against Listeria due to the organism's intrinsic structural differences in penicillin-binding proteins. Vancomycin also has poor and unreliable efficacy against this pathogen. Therefore, continuing ampicillin monotherapy aligns with both optimal clinical efficacy and essential antimicrobial stewardship principles by narrowing the spectrum of coverage.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical presentation.
The patient is an older adult (>50>50 years) presenting with acute bacterial meningitis, which correctly prompted an initial empirical regimen of ceftriaxone, vancomycin, and ampicillin.
Empirical coverage must target the most common pathogens: Streptococcus pneumoniae, Neisseria meningitidis (ceftriaxone/vancomycin), and Listeria monocytogenes (ampicillin in older or immunocompromised hosts).
2
Incorporate the microbiological data.
CSF culture has isolated Listeria monocytogenes.
Once a specific pathogen is identified, empirical therapy must be de-escalated to targeted therapy to follow antimicrobial stewardship principles.
3
Determine the targeted therapy for the isolated pathogen.
Ampicillin is the first-line treatment for Listeria monocytogenes.
Listeria is intrinsically resistant to all cephalosporins due to altered penicillin-binding proteins. Therefore, ceftriaxone and vancomycin provide no benefit and should be stopped to minimize toxicity and resistance.

Key Concept

Empirical antimicrobial therapy for bacterial meningitis must be narrowed to pathogen-directed therapy once culture results are available; for Listeria monocytogenes, ampicillin is the definitive treatment, and all cephalosporins are entirely ineffective.
Rate this question